BOULDER, Colo., June 8, 2026 /PRNewswire/ -- Embolization, Inc., will present its novel embolization device, using proprietary shape-memory biocompatible polymers to treat peripheral vasculature, June ...

The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery ...

Adding an immunotherapy-based regimen to standard treatment may improve outcomes for some patients with liver cancer who are ...

The Society of Interventional Radiology (SIR) published new practice guidance for the use of prostatic artery embolization (PAE) to treat enlarged prostate (also called benign prostatic hyperplasia or ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel ...

Patients receiving standard treatment for chronic subdural hematoma have a high risk of treatment failure. The effect of adjunctive middle meningeal artery embolization on the risk of treatment ...

The treatment of a subdural hematoma received a major boost with three new randomized controlled trials all showing large and significant benefits of a new embolization process done as an endovascular ...

PHOENIX -- For chronic or subacute subdural hematoma, embolization of the middle meningeal artery (MMA) reduced recurrence, three randomized trials showed. Two trials with the Onyx liquid embolic ...

Please provide your email address to receive an email when new articles are posted on . Benign prostatic hyperplasia is the most common benign tumor found in men. Prostate artery embolization is ...